Interestingly, when a similar number of the EphB2-driven mouse primary ependymoma tumor cells (tdNSCs) RGCH02 were intracranially implanted at our current site, we see a very different luminescence profile (Figure 3a; RGCH02) and survival curve (Figure 3d). This evidence concerns the gene EPHB2 and ependymoma.